These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2053593)

  • 1. Evidence for in vivo degradation of C3a anaphylatoxin by mast cell chymase. I. Nonspecific activation of rat peritoneal mast cells by C3ades Arg.
    Kajita T; Hugli TE
    Am J Pathol; 1991 Jun; 138(6):1359-69. PubMed ID: 2053593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
    Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
    J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control.
    Fukuoka Y; Hugli TE
    J Immunol; 1990 Sep; 145(6):1851-8. PubMed ID: 1697312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanism of action for anaphylatoxin C3a stimulation of mast cells.
    Mousli M; Hugli TE; Landry Y; Bronner C
    J Immunol; 1992 Apr; 148(8):2456-61. PubMed ID: 1373170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.
    el-Lati SG; Dahinden CA; Church MK
    J Invest Dermatol; 1994 May; 102(5):803-6. PubMed ID: 7513741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidergic pathway in human skin and rat peritoneal mast cell activation.
    Mousli M; Hugli TE; Landry Y; Bronner C
    Immunopharmacology; 1994; 27(1):1-11. PubMed ID: 7515863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat peritoneal mast cells produce IFN-gamma following IL-12 treatment but not in response to IgE-mediated activation.
    Gupta AA; Leal-Berumen I; Croitoru K; Marshall JS
    J Immunol; 1996 Sep; 157(5):2123-8. PubMed ID: 8757336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement peptide C3a inhibits IgE-mediated triggering of rat mucosal mast cells.
    Erdei A; Andreev S; Pecht I
    Int Immunol; 1995 Sep; 7(9):1433-9. PubMed ID: 7495751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells.
    Wells E; Jackson CG; Harper ST; Mann J; Eady RP
    J Immunol; 1986 Dec; 137(12):3941-5. PubMed ID: 2431049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The modulation by nedocromil sodium of proteases released from rat peritoneal mast cells capable of degrading vasoactive intestinal peptide and calcitonin gene-related peptide.
    Wilsoncroft P; Gaffen Z; Reynia S; Brain SD
    Immunopharmacology; 1993; 25(3):197-204. PubMed ID: 8394843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of the anaphylatoxins C3a and C5a on isolated mast cells from rat and man.
    Jürgensen H; Behrendt H; Damerau B; Schmutzler W
    Agents Actions; 1986 Apr; 18(1-2):153-4. PubMed ID: 2425572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Na+/K(+)-pump in rat peritoneal mast cells: some aspects of regulation of activity and cellular function.
    Knudsen T
    Dan Med Bull; 1995 Nov; 42(5):441-54. PubMed ID: 8747801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement peptides and mast cell triggering.
    Erdei A; Pecht I
    Immunol Lett; 1996 Dec; 54(2-3):109-12. PubMed ID: 9052863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody and inhibitor of chymase inhibit histamine release in immunoglobulin E-activated mast cells.
    Kido H; Fukusen N; Katunuma N
    Biochem Int; 1985 Jun; 10(6):863-71. PubMed ID: 2412558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cells are not required for anaphylatoxin-induced ileal smooth muscle contraction.
    Stimler-Gerard NP; Galli SJ
    J Immunol; 1987 Mar; 138(6):1908-13. PubMed ID: 2434565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase.
    Lindstedt KA; Wang Y; Shiota N; Saarinen J; Hyytiäinen M; Kokkonen JO; Keski-Oja J; Kovanen PT
    FASEB J; 2001 Jun; 15(8):1377-88. PubMed ID: 11387235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of rat serosal mast cells by chymase, an endogenous secretory granule protease.
    Schick B; Austen KF; Schwartz LB
    J Immunol; 1984 May; 132(5):2571-7. PubMed ID: 6425408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of chymase-mediated rat serosal mast cell degranulation by trypsin or diisopropyl fluorophosphate.
    Schick B; Austen KF
    Immunology; 1989 Mar; 66(3):434-8. PubMed ID: 2522909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of human C3a and the synthetic nonapeptide C3a (tyr-70-77) to rat peritoneal mast cells.
    Gervasoni JE; Ruddy S
    Prog Clin Biol Res; 1989; 297():221-31; discussion 231-2. PubMed ID: 2587586
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunocytochemical localization of chymase to cytoplasmic vesicles after rat peritoneal mast cell stimulation by compound 48/80.
    Login GR; Aoki M; Yamakawa M; Lunardi LO; Digenis EC; Tanda N; Schwartz LB; Dvorak AM
    J Histochem Cytochem; 1997 Oct; 45(10):1379-91. PubMed ID: 9313799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.